Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Ross

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Journal of Neurochemistry|January 1, 1987
Purification and amino terminal sequencing of human melanoma nerve growth factor receptorN Marano, B Dietzschold, J J Earley, et al.
Brain Research|February 9, 1988
Cultures of human Schwann cells isolated from fetal nervesE Scarpini, B Q Kreider, R P Lisak, et al.
Neurosurgery|July 1, 1990
Monoclonal antibody-dependent, cell-mediated cytotoxicity against human malignant gliomasH Takahashi, P H Belser, B F Atkinson, et al.
Cancer Research|June 1, 1988
Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progressionH Hotta, A H Ross, K Huebner, et al.
Journal of Neurosurgery|September 22, 2001
Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomasT Kubiatowski, T Jang, M B Lachyankar, et al.
The Journal of Cell Biology|March 1, 1996
The neurotrophin receptor, gp75, forms a complex with the receptor tyrosine kinase TrkAA H Ross, M C Daou, C A McKinnon, et al.
Hybridoma|January 1, 1985
Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumorsB Atkinson, C S Ernst, B F Ghrist, et al.
Biochemical Pharmacology|September 12, 2001
Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoidL D Recht, R Salmonsen, R Rosetti, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Introduction of nerve growth factor (NGF) receptors into a medulloblastoma cell line results in expression of high- and low-affinity NGF receptors but not NGF-mediated differentiationS J Pleasure, U R Reddy, G Venkatakrishnan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1984
Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodiesA H Ross, P Grob, M Bothwell, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Journal of Neurochemistry|January 1, 1987
Purification and amino terminal sequencing of human melanoma nerve growth factor receptorN Marano, B Dietzschold, J J Earley, et al.
Brain Research|February 9, 1988
Cultures of human Schwann cells isolated from fetal nervesE Scarpini, B Q Kreider, R P Lisak, et al.
Neurosurgery|July 1, 1990
Monoclonal antibody-dependent, cell-mediated cytotoxicity against human malignant gliomasH Takahashi, P H Belser, B F Atkinson, et al.
Cancer Research|June 1, 1988
Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progressionH Hotta, A H Ross, K Huebner, et al.
Journal of Neurosurgery|September 22, 2001
Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomasT Kubiatowski, T Jang, M B Lachyankar, et al.
The Journal of Cell Biology|March 1, 1996
The neurotrophin receptor, gp75, forms a complex with the receptor tyrosine kinase TrkAA H Ross, M C Daou, C A McKinnon, et al.
Hybridoma|January 1, 1985
Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumorsB Atkinson, C S Ernst, B F Ghrist, et al.
Biochemical Pharmacology|September 12, 2001
Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoidL D Recht, R Salmonsen, R Rosetti, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Introduction of nerve growth factor (NGF) receptors into a medulloblastoma cell line results in expression of high- and low-affinity NGF receptors but not NGF-mediated differentiationS J Pleasure, U R Reddy, G Venkatakrishnan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1984
Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodiesA H Ross, P Grob, M Bothwell, et al.
Pageof 16